• Personalized Medicine is often defined as “the right treatment for the right person at the right time.”• Personalized Medicine (PMx) testing remains a phenomenon of the developed world. At least 80% of the PMx tests performed are concentrated in the developed world-North America and Western Europe. • Point of care test (POCT) and molecular diagnostics is expected to expand dramatically in the next couple of years. These two segments grabbed over 40% and 25% market share in 2012 respectively. • The Pharmacogenetics market is predicted to grow with a compound annual growth rate of over 10% for the period of 2013-2018.• The Cardiovascular Management test market is anticipated grow with a CAGR of around 5% for the spanning period of 2013 - 2018.
Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)” report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market. This report contains 12 chapters
• Chapter 1 is Executive Summary • Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 – 2018). The market includes technological & disease-wise personalized medicine diagnostics market • Chapter 3 contains worldwide personalized medicine diagnostic market share segment. Segment include Technology, Disease-Wise • Chapter 4 contains segment-wise technological personalized diagnostic market & forecast (2010 - 2018) • Chapter 5 contains geographical segment-wise personalized diagnostic market & forecast (2011 - 2018) • Chapter 6 contains disease-wise personalized diagnostic market share & forecast (2011 - 2018) • Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 - 2018) • Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics Medicine Market • Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine • Chapter 12 contains company analysis of Personalized Medicine Companies analyzed in this report are: • HistoRx • A&G Pharmaceuticals Inc • 20/20 GeneSystems • Tethys Bioscience • Genomas Inc Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Click here to view the report Details: http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-market-forecast-116
For more information visit: http://www.renub.com/
Rajat GuptaSr. ManagerSales & Marketing DivRenub ResearchEmail: firstname.lastname@example.org Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)Web: http://www.renub.com
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.